Clinical magnitude, contemporary treatment gaps, hyperkalemia risk, and the pharmacoeconomic limits of a potential non-diabetic CKD expansion
Clinical magnitude, contemporary treatment gaps, hyperkalemia risk, and the pharmacoeconomic limits of a potential non-diabetic CKD expansion
